Resurgent Financial Advisors LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1912339
ATLANTA, GA
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$166,618
+$30,924 QoQ
Shares Held
45,400
+2.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#160
of 340 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Jun 30, 2026CallValue
$3,670
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resurgent Financial Advisors LLC holds $166,618 across 1 Biotechnology name. RXRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
45,400 | $166,618 |
All Filings in RXRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,670 | 1,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $166,618 | 45,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $135,694 | 44,200 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $83,027 | 20,300 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||